Kalytera Announces Initiation of Phase 2 Clinical Study in Prevention of Graft Versus Host Disease and Agreement with The Salzman Group of Israel to Manage and Partially Fund the Study to be Led by a World Class Team Cannabis Investing News
3D Signatures Inc. Announces the Closing of its Non-Brokered Private Placement Pharmaceutical Investing
Novoheart Publishes New Study Showing Machine Learning Use to Accelerate Drug Screening Biotech Investing
